Merrimack Pharmaceuticals CEO Richard Peters' 2018 pay slips 13% to $3.3M
Merrimack Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: September 26, 2019
Merrimack Pharmaceuticals reported fiscal year 2018 executive compensation information on September 26, 2019.
In 2018, three executives at Merrimack Pharmaceuticals received on average a compensation package of $1.7M, a 59% increase compared to previous year.
Average pay of disclosed executives at Merrimack Pharmaceuticals
Richard Peters, Chief Executive Officer, received $3.3M in total, which decreased by 13% compared to 2017. 59% of Peters' compensation, or $2M, was in option awards. Peters also received $610K in non-equity incentive plan, $722K in salary, as well as $10K in other compensation.
Jean M. Franchi, Chief Financial Officer, received a compensation package of $967K, which increased by 51% compared to previous year. 42% of the compensation package, or $403K, was in salary.
Sergio L. Santillana, Chief Medical Officer, earned $925K in 2018, a 42% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on September 26, 2019.